Considerations for the optimization of induced white matter injury preclinical models

Frontiers in Neurology

Volumn 6, Issue Aug, 2015, Pages

  Ahmad, Abdullah Shafique ^a   Satriotomo, Irawan ^a   Fazal, Jawad ^a   Nadeau, Stephen E ^b,c   Doré, Sylvain ^a,b,c,d  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d NONE   (United States)

Author keywords

Corpus callosum; Lysophosphatidylcholine; Mouse; NOS inhibitor; Posterior limb internal capsule; Stroke; Vasoconstriction

Indexed keywords

ENDOTHELIN 1; ETHIDIUM BROMIDE; LIPOPOLYSACCHARIDE; LYSOPHOSPHATIDYLCHOLINE; MYELIN; N(G) NITROARGININE METHYL ESTER; N5 (1 IMINOETHYL)ORNITHINE; NITRIC OXIDE SYNTHASE INHIBITOR; QUINOLINIC ACID;

BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN DEVELOPMENT; BRAIN ISCHEMIA; BRAIN PERFUSION; CEREBROVASCULAR ACCIDENT; DEMYELINATING DISEASE; DIFFUSION TENSOR IMAGING; DISEASE ACTIVITY; ENCEPHALOMALACIA; FUNCTIONAL DISEASE; HUMAN; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIVENTRICULAR WHITE MATTER; POSTERIOR LIMB INTERNAL CAPSULE; REVIEW; TRAUMATIC BRAIN INJURY; WHITE MATTER; WHITE MATTER INJURY;

EID: 84941006843     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2015.00172     Document Type: Review

References (167)

1. Zhang K, Sejnowski TJ. A universal scaling law between gray matter and white matter of cerebral cortex. Proc Natl Acad Sci U S A (2000) 97:5621-6. doi: 10.1073/pnas.090504197
2. Leys D, Englund E, Del Ser T, Inzitari D, Fazekas F, Bornstein N, et al. White matter changes in stroke patients. Relationship with stroke subtype and outcome. Eur Neurol (1999) 42:67-75. doi:10.1159/000069414
3. Pantoni L, Leys D, Fazekas F, Longstreth WT Jr, Inzitari D, Wallin A, et al. Role of white matter lesions in cognitive impairment of vascular origin. Alzheimer Dis Assoc Disord (1999) 13(Suppl 3):S49-54. doi:10.1097/00002093-199912001-00008
4. Goldberg MP, Ransom BR. New light on white matter. Stroke (2003) 34:330-2. doi:10.1161/01.STR.0000054048.22626.B9
5. Leviton A, Gilles F, Neff R, Yaney P. Multivariate analysis of risk of perinatal telencephalic leucoencephalopathy. Am J Epidemiol (1976) 104:621-6.
6. Prins ND, Van Dijk EJ, Den Heijer T, Vermeer SE, Koudstaal PJ, Oudkerk M, et al. Cerebral white matter lesions and the risk of dementia. Arch Neurol (2004) 61:1531-4. doi:10.1001/archneur.61.10.1531
7. Kaur C, Sivakumar V, Ang LS, Sundaresan A. Hypoxic damage to the periventricular white matter in neonatal brain: role of vascular endothelial growth factor, nitric oxide and excitotoxicity. J Neurochem (2006) 98:1200-16. doi:10.1111/j.1471-4159.2006.03964.x
8. Puig J, Pedraza S, Blasco G, Daunis IEJ, Prados F, Remollo S, et al. Acute damage to the posterior limb of the internal capsule on diffusion tensor tractography as an early imaging predictor of motor outcome after stroke. AJNR Am J Neuroradiol (2011) 32:857-63. doi:10.3174/ajnr.A2400
9. Hedna VS, Jain S, Rabbani O, Nadeau SE. Mechanisms of arm paresis in middle cerebral artery distribution stroke: pilot study. J Rehabil Res Dev (2013) 50:1113-22. doi:10.1682/JRRD.2012.10.0194
10. Shi H, Hu X, Leak RK, Shi Y, An C, Suenaga J, et al. Demyelination as a rational therapeutic target for ischemic or traumatic brain injury. Exp Neurol (2015). doi:10.1016/j.expneurol.2015.03.017
11. Assareh A, Mather KA, Schofield PR, Kwok JB, Sachdev PS. The genetics of white matter lesions. CNS Neurosci Ther (2011) 17:525-40. doi:10.1111/j.1755-5949.2010.00181.x
12. Matute C, Ransom BR. Roles of white matter in central nervous system pathophysiologies. ASN Neuro (2012) 4:e00079. doi:10.1042/AN20110060
13. Sozmen EG, Hinman JD, Carmichael ST. Models that matter: white matter stroke models. Neurotherapeutics (2012) 9:349-58. doi:10.1007/s13311-012-0106-0
14. Matute C, Domercq M, Perez-Samartin A, Ransom BR. Protecting white matter from stroke injury. Stroke (2013) 44:1204-11. doi:10.1161/STROKEAHA.112.658328
15. Falcone GJ, Malik R, Dichgans M, Rosand J. Current concepts and clinical applications of stroke genetics. Lancet Neurol (2014) 13:405-18. doi:10.1016/S1474-4422(14)70029-8
16. Fern RF, Matute C, Stys PK. White matter injury: ischemic and nonischemic. Glia (2014) 62:1780-9. doi:10.1002/glia.22722
17. Armstrong RC, Mierzwa AJ, Marion CM, Sullivan GM. White matter involvement after TBI: clues to axon and myelin repair capacity. Exp Neurol (2015). doi:10.1016/j.expneurol.2015.02.011
18. Glushakova OY, Johnson D, Hayes RL. Delayed increases in microvascular pathology after experimental traumatic brain injury are associated with prolonged inflammation, blood-brain barrier disruption, and progressive white matter damage. J Neurotrauma (2014) 31:1180-93. doi:10.1089/neu.2013.3080
19. Weaver J, Jalal FY, Yang Y, Thompson J, Rosenberg GA, Liu KJ. Tissue oxygen is reduced in white matter of spontaneously hypertensive-stroke prone rats: a longitudinal study with electron paramagnetic resonance. J Cereb Blood Flow Metab (2014) 34:890-6. doi:10.1038/jcbfm.2014.35
20. Jalal FY, Yang Y, Thompson JF, Roitbak T, Rosenberg GA. Hypoxia-induced neuroinflammatory white-matter injury reduced by minocycline in SHR/SP. J Cereb Blood Flow Metab (2015) 35(7):1145-53. doi:10.1038/jcbfm.2015.21
21. Sozmen EG, Kolekar A, Havton LA, Carmichael ST. A white matter stroke model in the mouse: axonal damage, progenitor responses and MRI correlates. J Neurosci Methods (2009) 180:261-72. doi:10.1016/j.jneumeth.2009.03.017
22. Horie N, Maag AL, Hamilton SA, Shichinohe H, Bliss TM, Steinberg GK. Mouse model of focal cerebral ischemia using endothelin-1. J Neurosci Methods (2008) 173:286-90. doi:10.1016/j.jneumeth.2008.06.013
23. Hughes PM, Anthony DC, Ruddin M, Botham MS, Rankine EL, Sablone M, et al. Focal lesions in the rat central nervous system induced by endothelin-1. J Neuropathol Exp Neurol (2003) 62:1276-86.
24. Frost SB, Barbay S, Mumert ML, Stowe AM, Nudo RJ. An animal model of capsular infarct: endothelin-1 injections in the rat. Behav Brain Res (2006) 169:206-11. doi:10.1016/j.bbr.2006.01.014
25. Lecrux C, McCabe C, Weir CJ, Gallagher L, Mullin J, Touzani O, et al. Effects of magnesium treatment in a model of internal capsule lesion in spontaneously hypertensive rats. Stroke (2008) 39:448-54. doi:10.1161/STROKEAHA.107.492934
26. Blasi F, Whalen MJ, Ayata C. Lasting pure-motor deficits after focal posterior internal capsule white-matter infarcts in rats. J Cereb Blood Flow Metab (2015) 35:977-84. doi:10.1038/jcbfm.2015.7
27. He Z, Yamawaki T, Yang S, Day AL, Simpkins JW, Naritomi H. Experimental model of small deep infarcts involving the hypothalamus in rats: changes in body temperature and postural reflex. Stroke (1999) 30:2743-51. doi:10.1161/01.STR.30.12.2743
28. Tanaka Y, Imai H, Konno K, Miyagishima T, Kubota C, Puentes S, et al. Experimental model of lacunar infarction in the gyrencephalic brain of the miniature pig: neurological assessment and histological, immunohistochemical, and physiological evaluation of dynamic corticospinal tract deformation. Stroke (2008) 39:205-12. doi:10.1161/STROKEAHA.107.489906
29. Jean I, Allamargot C, Barthelaix-Pouplard A, Fressinaud C. Axonal lesions and PDGF-enhanced remyelination in the rat corpus callosum after lysolecithin demyelination. Neuroreport (2002) 13:627-31. doi:10.1097/00001756-200204160-00018
30. Jean I, Lavialle C, Barthelaix-Pouplard A, Fressinaud C. Neurotrophin-3 specifically increases mature oligodendrocyte population and enhances remyelination after chemical demyelination of adult rat CNS. Brain Res (2003) 972:110-8. doi:10.1016/S0006-8993(03)02510-1
31. Pham LD, Hayakawa K, Seo JH, Nguyen MN, Som AT, Lee BJ, et al. Crosstalk between oligodendrocytes and cerebral endothelium contributes to vascular remodeling after white matter injury. Glia (2012) 60:875-81. doi:10.1002/glia.22320
32. Hinman JD, Rasband MN, Carmichael ST. Remodeling of the axon initial segment after focal cortical and white matter stroke. Stroke (2013) 44:182-9. doi:10.1161/STROKEAHA.112.668749
33. Clarner T, Diederichs F, Berger K, Denecke B, Gan L, Van Der Valk P, et al. Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions. Glia (2012) 60:1468-80. doi:10.1002/glia.22367
34. Ni J, Ohta H, Matsumoto K, Watanabe H. Progressive cognitive impairment following chronic cerebral hypoperfusion induced by permanent occlusion of bilateral carotid arteries in rats. Brain Res (1994) 653:231-6. doi:10.1016/0006-8993(94)90394-8
35. Shibata M, Ohtani R, Ihara M, Tomimoto H. White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke (2004) 35:2598-603. doi:10.1161/01.STR.0000143725.19053.60
36. Shibata M, Yamasaki N, Miyakawa T, Kalaria RN, Fujita Y, Ohtani R, et al. Selective impairment of working memory in a mouse model of chronic cerebral hypoperfusion. Stroke (2007) 38:2826-32. doi:10.1161/STROKEAHA.107.490151
37. Hattori H, Takeda M, Kudo T, Nishimura T, Hashimoto S. Cumulative white matter changes in the gerbil brain under chronic cerebral hypoperfusion. Acta Neuropathol (1992) 84:437-42. doi:10.1007/BF00227672
38. Kudo T, Tada K, Takeda M, Nishimura T. Learning impairment and microtubule-associated protein 2 decrease in gerbils under chronic cerebral hypoperfusion. Stroke (1990) 21:1205-9. doi:10.1161/01.STR.21.8.1205
39. Kudo T, Takeda M, Tanimukai S, Nishimura T. Neuropathologic changes in the gerbil brain after chronic hypoperfusion. Stroke (1993) 24:259-64. doi:10.1161/01.STR.24.2.259
40. Hattori Y, Enmi J, Kitamura A, Yamamoto Y, Saito S, Takahashi Y, et al. A novel mouse model of subcortical infarcts with dementia. J Neurosci (2015) 35:3915-28. doi:10.1523/JNEUROSCI.3970-14.2015
41. Lubics A, Reglodi D, Tamas A, Kiss P, Szalai M, Szalontay L, et al. Neurological reflexes and early motor behavior in rats subjected to neonatal hypoxic-ischemic injury. Behav Brain Res (2005) 157:157-65. doi:10.1016/j.bbr.2004.06.019
42. Wang LS, Zhou J, Shao XM, Tang XC. Huperzine A attenuates cognitive deficits and brain injury in neonatal rats after hypoxia-ischemia. Brain Res (2002) 949:162-70. doi:10.1016/S0006-8993(02)02977-3
43. Shen Y, Plane JM, Deng W. Mouse models of periventricular leukomalacia. J Vis Exp (2010) e1951. doi:10.3791/1951
44. Rousset CI, Kassem J, Aubert A, Planchenault D, Gressens P, Chalon S, et al. Maternal exposure to lipopolysaccharide leads to transient motor dysfunction in neonatal rats. Dev Neurosci (2013) 35:172-81. doi:10.1159/000346579
45. Mathai S, Booth LC, Davidson JO, Drury PP, Fraser M, Jensen EC, et al. Acute on chronic exposure to endotoxin in preterm fetal sheep. Am J Physiol Regul Integr Comp Physiol (2013) 304:R189-97. doi:10.1152/ajpregu.00388.2012
46. Duncan JR, Cock ML, Scheerlinck JP, Westcott KT, McLean C, Harding R, et al. White matter injury after repeated endotoxin exposure in the preterm ovine fetus. Pediatr Res (2002) 52:941-9. doi:10.1203/00006450-200212000-00021
47. Ward P, Counsell S, Allsop J, Cowan F, Shen Y, Edwards D, et al. Reduced fractional anisotropy on diffusion tensor magnetic resonance imaging after hypoxic-ischemic encephalopathy. Pediatrics (2006) 117:e619-30. doi:10.1542/peds.2005-0545
48. Vannucci RC, Vannucci SJ. Perinatal hypoxic-ischemic brain damage: evolution of an animal model. Dev Neurosci (2005) 27:81-6. doi:10.1159/000085978
49. Rezaie P, Dean A. Periventricular leukomalacia, inflammation and white matter lesions within the developing nervous system. Neuropathology (2002) 22:106-32. doi:10.1046/j.1440-1789.2002.00438.x
50. Khwaja O, Volpe JJ. Pathogenesis of cerebral white matter injury of prematurity. Arch Dis Child Fetal Neonatal Ed (2008) 93:F153-61. doi:10.1136/adc.2006.108837
51. Vannucci RC, Connor JR, Mauger DT, Palmer C, Smith MB, Towfighi J, et al. Rat model of perinatal hypoxic-ischemic brain damage. J Neurosci Res (1999) 55:158-63. doi:10.1002/(SICI)1097-4547(19990115)55:2<158::AID-JNR3>3.0.CO;2-1
52. Bracco L, Piccini C, Moretti M, Mascalchi M, Sforza A, Nacmias B, et al. Alzheimer's disease: role of size and location of white matter changes in determining cognitive deficits. Dement Geriatr Cogn Disord (2005) 20:358-66. doi:10.1159/000088562
53. Kim YS, Lee KM, Choi BH, Sohn EH, Lee AY. Relation between the clock drawing test (CDT) and structural changes of brain in dementia. Arch Gerontol Geriatr (2009) 48:218-21. doi:10.1016/j.archger.2008.01.010
54. Tullberg M, Hultin L, Ekholm S, Mansson JE, Fredman P, Wikkelso C. White matter changes in normal pressure hydrocephalus and Binswanger disease: specificity, predictive value and correlations to axonal degeneration and demyelination. Acta Neurol Scand (2002) 105:417-26. doi:10.1034/j.1600-0404.2002.01189.x
55. Cho ZH, Law M, Chi JG, Choi SH, Park SY, Kammen A, et al. An anatomic review of thalamolimbic fiber tractography: ultra-high resolution direct visualization of thalamolimbic fibers anterior thalamic radiation, superolateral and inferomedial medial forebrain bundles, and newly identified septum pellucidum tract. World Neurosurg (2013) 83:54-61. doi:10.1016/j.wneu.2013.08.022
56. Yanagisawa M, Kurihara H, Kimura S, Goto K, Masaki T. A novel peptide vasoconstrictor, endothelin, is produced by vascular endothelium and modulates smooth muscle Ca2+ channels. J Hypertens Suppl (1988) 6:S188-91. doi:10.1097/00004872-198812040-00056
57. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (1988) 332:411-5. doi:10.1038/332411a0
58. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev (1994) 46:325-415.
59. Kedzierski RM, Yanagisawa M. Endothelin system: the double-edged sword in health and disease. Annu Rev Pharmacol Toxicol (2001) 41:851-76. doi:10.1146/annurev.pharmtox.41.1.851
60. Giaid A, Gibson SJ, Ibrahim BN, Legon S, Bloom SR, Yanagisawa M, et al. Endothelin 1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia. Proc Natl Acad Sci U S A (1989) 86:7634-8. doi:10.1073/pnas.86.19.7634
61. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature (1990) 348:730-2. doi:10.1038/348730a0
62. Ehrenreich H, Anderson RW, Fox CH, Rieckmann P, Hoffman GS, Travis WD, et al. Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J Exp Med (1990) 172:1741-8. doi:10.1084/jem.172.6.1741
63. MacCumber MW, Ross CA, Snyder SH. Endothelin in brain: receptors, mitogenesis, and biosynthesis in glial cells. Proc Natl Acad Sci U S A (1990) 87:2359-63. doi:10.1073/pnas.87.6.2359
64. Lee ME, De La Monte SM, Ng SC, Bloch KD, Quertermous T. Expression of the potent vasoconstrictor endothelin in the human central nervous system. J Clin Invest (1990) 86:141-7. doi:10.1172/JCI114677
65. Yoshizawa T, Shinmi O, Giaid A, Yanagisawa M, Gibson SJ, Kimura S, et al. Endothelin: a novel peptide in the posterior pituitary system. Science (1990) 247:462-4. doi:10.1126/science.2405487
66. Giaid A, Gibson SJ, Herrero MT, Gentleman S, Legon S, Yanagisawa M, et al. Topographical localisation of endothelin mRNA and peptide immunoreactivity in neurones of the human brain. Histochemistry (1991) 95:303-14. doi:10.1007/BF00266781
67. Koseki C, Imai M, Hirata Y, Yanagisawa M, Masaki T. Autoradiographic localization of [125I]-endothelin-1 binding sites in rat brain. Neurosci Res (1989) 6:581-5. doi:10.1016/0168-0102(89)90047-3
68. Kadel KA, Heistad DD, Faraci FM. Effects of endothelin on blood vessels of the brain and choroid plexus. Brain Res (1990) 518:78-82. doi:10.1016/0006-8993(90)90956-C
69. Sakurai T, Yanagisawa M, Masaki T. Molecular characterization of endothelin receptors. Trends Pharmacol Sci (1992) 13:103-8. doi:10.1016/0165-6147(92)90038-8
70. Kuwaki T, Kurihara H, Cao WH, Kurihara Y, Unekawa M, Yazaki Y, et al. Physiological role of brain endothelin in the central autonomic control: from neuron to knockout mouse. Prog Neurobiol (1997) 51:545-79. doi:10.1016/S0301-0082(96)00063-9
71. Souza-Rodrigues RD, Costa AM, Lima RR, Dos Santos CD, Picanco-Diniz CW, Gomes-Leal W. Inflammatory response and white matter damage after microinjections of endothelin-1 into the rat striatum. Brain Res (2008) 1200:78-88. doi:10.1016/j.brainres.2007.11.025
72. Robinson MJ, Macrae IM, Todd M, Reid JL, McCulloch J. Reduction of local cerebral blood flow to pathological levels by endothelin-1 applied to the middle cerebral artery in the rat. Neurosci Lett (1990) 118:269-72. doi:10.1016/0304-3940(90)90644-O
73. Willette RN, Sauermelch CF. Abluminal effects of endothelin in cerebral microvasculature assessed by laser-Doppler flowmetry. Am J Physiol (1990) 259:H1688-93.
74. Fuxe K, Kurosawa N, Cintra A, Hallstrom A, Goiny M, Rosen L, et al. Involvement of local ischemia in endothelin-1 induced lesions of the neostriatum of the anaesthetized rat. Exp Brain Res (1992) 88:131-9. doi:10.1007/BF02259134
75. Windle V, Szymanska A, Granter-Button S, White C, Buist R, Peeling J, et al. An analysis of four different methods of producing focal cerebral ischemia with endothelin-1 in the rat. Exp Neurol (2006) 201:324-34. doi:10.1016/j.expneurol.2006.04.012
76. Ziv I, Fleminger G, Djaldetti R, Achiron A, Melamed E, Sokolovsky M. Increased plasma endothelin-1 in acute ischemic stroke. Stroke (1992) 23:1014-6. doi:10.1161/01.STR.23.7.1014
77. Fuxe K, Cintra A, Andbjer B, Anggard E, Goldstein M, Agnati LF. Centrally administered endothelin-1 produces lesions in the brain of the male rat. Acta Physiol Scand (1989) 137:155-6. doi:10.1111/j.1748-1716.1989.tb08734.x
78. Gilmour G, Iversen SD, O'neill MF, Bannerman DM. The effects of intracortical endothelin-1 injections on skilled forelimb use: implications for modelling recovery of function after stroke. Behav Brain Res (2004) 150:171-83. doi:10.1016/j.bbr.2003.07.006
79. Wang Y, Jin K, Greenberg DA. Neurogenesis associated with endothelin-induced cortical infarction in the mouse. Brain Res (2007) 1167:118-22. doi:10.1016/j.brainres.2007.06.065
80. Wiley KE, Davenport AP. Endothelin receptor pharmacology and function in the mouse: comparison with rat and man. J Cardiovasc Pharmacol (2004) 44(Suppl 1):S4-6. doi:10.1097/01.fjc.0000166204.89426.20
81. Babu BR, Griffith OW. Design of isoform-selective inhibitors of nitric oxide synthase. Curr Opin Chem Biol (1998) 2:491-500. doi:10.1016/S1367-5931(98)80125-7
82. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science (1994) 265:1883-5. doi:10.1126/science.7522345
83. Zhao X, Haensel C, Araki E, Ross ME, Iadecola C. Gene-dosing effect and persistence of reduction in ischemic brain injury in mice lacking inducible nitric oxide synthase. Brain Res (2000) 872:215-8. doi:10.1016/S0006-8993(00)02459-8
84. Gross SS, Wolin MS. Nitric oxide: pathophysiological mechanisms. Annu Rev Physiol (1995) 57:737-69. doi:10.1146/annurev.ph.57.030195.003513
85. Scorziello A, Santillo M, Adornetto A, Dell'aversano C, Sirabella R, Damiano S, et al. NO-induced neuroprotection in ischemic preconditioning stimulates mitochondrial Mn-SOD activity and expression via Ras/ERK1/2 pathway. J Neurochem (2007) 103:1472-80. doi:10.1111/j.1471-4159.2007.04845.x
86. Chen ZY, Wang L, Asavaritkrai P, Noguchi CT. Up-regulation of erythropoietin receptor by nitric oxide mediates hypoxia preconditioning. J Neurosci Res (2010) 88:3180-8. doi:10.1002/jnr.22473
87. Peng B, Guo QL, He ZJ, Ye Z, Yuan YJ, Wang N, et al. Remote ischemic postconditioning protects the brain from global cerebral ischemia/reperfusion injury by up-regulating endothelial nitric oxide synthase through the PI3K/Akt pathway. Brain Res (2012) 1445:92-102. doi:10.1016/j.brainres.2012.01.033
88. Widdop RE, Gardiner SM, Kemp PA, Bennett T. The influence of atropine and atenolol on the cardiac haemodynamic effects of NG-nitro-L-arginine methyl ester in conscious, Long Evans rats. Br J Pharmacol (1992) 105:653-6. doi:10.1111/j.1476-5381.1992.tb09034.x
89. Ferreira-Melo SE, Yugar-Toledo JC, Coelho OR, De Luca IM, Tanus-Santos JE, Hyslop S, et al. Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats. Eur J Pharmacol (2006) 542:141-7. doi:10.1016/j.ejphar.2006.04.039
90. Galasso JM, Bazzett TJ, Becker JB, Albin RL. Synergistic effect of intrastriatal co-administration of L-NAME and quinolinic acid. Neuroreport (1995) 6:1505-8. doi:10.1097/00001756-199507310-00010
91. Ashwal S, Cole DJ, Osborne S, Osborne TN, Pearce WJ. L-NAME reduces infarct volume in a filament model of transient middle cerebral artery occlusion in the rat pup. Pediatr Res (1995) 38:652-6. doi:10.1203/00006450-199511000-00004
92. Quast MJ, Wei J, Huang NC. Nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester decreases ischemic damage in reversible focal cerebral ischemia in hyperglycemic rats. Brain Res (1995) 677:204-12. doi:10.1016/0006-8993(95)00134-C
93. Ding-Zhou L, Marchand-Verrecchia C, Croci N, Plotkine M, Margaill I. L-NAME reduces infarction, neurological deficit and blood-brain barrier disruption following cerebral ischemia in mice. Eur J Pharmacol (2002) 457:137-46. doi:10.1016/S0014-2999(02)02686-9
94. Mulligan MS, Moncada S, Ward PA. Protective effects of inhibitors of nitric oxide synthase in immune complex-induced vasculitis. Br J Pharmacol (1992) 107:1159-62. doi:10.1111/j.1476-5381.1992.tb13423.x
95. McCall TB, Feelisch M, Palmer RM, Moncada S. Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells. Br J Pharmacol (1991) 102:234-8. doi:10.1111/j.1476-5381.1991.tb12159.x
96. Blakemore WF. Ethidium bromide induced demyelination in the spinal cord of the cat. Neuropathol Appl Neurobiol (1982) 8:365-75. doi:10.1111/j.1365-2990.1982.tb00305.x
97. Loy DN, Magnuson DS, Zhang YP, Onifer SM, Mills MD, Cao QL, et al. Functional redundancy of ventral spinal locomotor pathways. J Neurosci (2002) 22:315-23.
98. Loy DN, Talbott JF, Onifer SM, Mills MD, Burke DA, Dennison JB, et al. Both dorsal and ventral spinal cord pathways contribute to overground locomotion in the adult rat. Exp Neurol (2002) 177:575-80. doi:10.1006/exnr.2002.7959
99. Kuypers NJ, James KT, Enzmann GU, Magnuson DS, Whittemore SR. Functional consequences of ethidium bromide demyelination of the mouse ventral spinal cord. Exp Neurol (2013) 247:615-22. doi:10.1016/j.expneurol.2013.02.014
100. Woodruff RH, Franklin RJ. Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: a comparative study. Glia (1999) 25:216-28. doi:10.1002/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L
101. Hayashi J, Tanaka M, Sato W, Ozawa T, Yonekawa H, Kagawa Y, et al. Effects of ethidium bromide treatment of mouse cells on expression and assembly of nuclear-coded subunits of complexes involved in the oxidative phosphorylation. Biochem Biophys Res Commun (1990) 167:216-21. doi:10.1016/0006-291X(90)91753-F
102. Hayakawa T, Noda M, Yasuda K, Yorifuji H, Taniguchi S, Miwa I, et al. Ethidium bromide-induced inhibition of mitochondrial gene transcription suppresses glucose-stimulated insulin release in the mouse pancreatic beta-cell line betaHC9. J Biol Chem (1998) 273:20300-7. doi:10.1074/jbc.273.32.20300
103. Blakemore WF. The case for a central nervous system (CNS) origin for the Schwann cells that remyelinate CNS axons following concurrent loss of oligodendrocytes and astrocytes. Neuropathol Appl Neurobiol (2005) 31:1-10. doi:10.1111/j.1365-2990.2005.00637.x
104. Titsworth WL, Onifer SM, Liu NK, Xu XM. Focal phospholipases A2 group III injections induce cervical white matter injury and functional deficits with delayed recovery concomitant with Schwann cell remyelination. Exp Neurol (2007) 207:150-62. doi:10.1016/j.expneurol.2007.06.010
105. Matsumoto T, Kobayashi T, Kamata K. Role of lysophosphatidylcholine (LPC) in atherosclerosis. Curr Med Chem (2007) 14:3209-20. doi:10.2174/092986707782793899
106. Larsen PH, Wells JE, Stallcup WB, Opdenakker G, Yong VW. Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan. J Neurosci (2003) 23:11127-35.
107. Kotter MR, Zhao C, Van Rooijen N, Franklin RJ. Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiol Dis (2005) 18:166-75. doi:10.1016/j.nbd.2004.09.019
108. Birgbauer E, Rao TS, Webb M. Lysolecithin induces demyelination in vitro in a cerebellar slice culture system. J Neurosci Res (2004) 78:157-66. doi:10.1002/jnr.20248
109. Ousman SS, David S. Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord. Glia (2000) 30:92-104. doi:10.1002/(SICI)1098-1136(200003)30:1<92::AID-GLIA10>3.3.CO;2-N
110. Ousman SS, David S. MIP-1alpha, MCP-1, GM-CSF, and TNF-alpha control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord. J Neurosci (2001) 21:4649-56.
111. Ghasemlou N, Jeong SY, Lacroix S, David S. T cells contribute to lysophosphatidylcholine-induced macrophage activation and demyelination in the CNS. Glia (2007) 55:294-302. doi:10.1002/glia.20449
112. Jeffery ND, Blakemore WF. Remyelination of mouse spinal cord axons demyelinated by local injection of lysolecithin. J Neurocytol (1995) 24:775-81. doi:10.1007/BF01191213
113. Yoon BH, Jun JK, Romero R, Park KH, Gomez R, Choi JH, et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol (1997) 177:19-26. doi:10.1016/S0002-9378(97)70276-X
114. Sheldon RA, Chuai J, Ferriero DM. A rat model for hypoxic-ischemic brain damage in very premature infants. Biol Neonate (1996) 69:327-41. doi:10.1159/000244327
115. Vannucci RC, Brucklacher RM, Vannucci SJ. Glycolysis and perinatal hypoxic-ischemic brain damage. Dev Neurosci (2005) 27:185-90. doi:10.1159/000085991
116. Back SA, Han BH, Luo NL, Chricton CA, Xanthoudakis S, Tam J, et al. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci (2002) 22:455-63.
117. Yatomi Y, Tanaka R, Shimura H, Miyamoto N, Yamashiro K, Takanashi M, et al. Chronic brain ischemia induces the expression of glial glutamate transporter EAAT2 in subcortical white matter. Neuroscience (2013) 244:113-21. doi:10.1016/j.neuroscience.2013.04.018
118. Ueno M, Tomimoto H, Akiguchi I, Wakita H, Sakamoto H. Blood-brain barrier disruption in white matter lesions in a rat model of chronic cerebral hypoperfusion. J Cereb Blood Flow Metab (2002) 22:97-104. doi:10.1097/00004647-200201000-00012
119. Goepfert AR, Andrews WW, Carlo W, Ramsey PS, Cliver SP, Goldenberg RL, et al. Umbilical cord plasma interleukin-6 concentrations in preterm infants and risk of neonatal morbidity. Am J Obstet Gynecol (2004) 191:1375-81. doi:10.1016/j.ajog.2004.06.086
120. Cai Z, Pan ZL, Pang Y, Evans OB, Rhodes PG. Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatr Res (2000) 47:64-72. doi:10.1203/00006450-200001000-00013
121. Bell MJ, Hallenbeck JM, Gallo V. Determining the fetal inflammatory response in an experimental model of intrauterine inflammation in rats. Pediatr Res (2004) 56:541-6. doi:10.1203/01.PDR.0000139407.89883.6B
122. Kohmura Y, Kirikae T, Kirikae F, Nakano M, Sato I. Lipopolysaccharide (LPS)-induced intra-uterine fetal death (IUFD) in mice is principally due to maternal cause but not fetal sensitivity to LPS. Microbiol Immunol (2000) 44:897-904. doi:10.1111/j.1348-0421.2000.tb02581.x
123. Paintlia MK, Paintlia AS, Khan M, Singh I, Singh AK. Modulation of peroxisome proliferator-activated receptor-alpha activity by N-acetyl cysteine attenuates inhibition of oligodendrocyte development in lipopolysaccharide stimulated mixed glial cultures. J Neurochem (2008) 105:956-70. doi:10.1111/j.1471-4159.2007.05199.x
124. Chamnanvanakij S, Margraf LR, Burns D, Perlman JM. Apoptosis and white matter injury in preterm infants. Pediatr Dev Pathol (2002) 5:184-9. doi:10.1007/s10024-001-0205-0
125. Yonezawa M, Back SA, Gan X, Rosenberg PA, Volpe JJ. Cystine deprivation induces oligodendroglial death: rescue by free radical scavengers and by a diffusible glial factor. J Neurochem (1996) 67:566-73. doi:10.1046/j.1471-4159.1996.67020566.x
126. Baerwald KD, Popko B. Developing and mature oligodendrocytes respond differently to the immune cytokine interferon-gamma. J Neurosci Res (1998) 52:230-9. doi:10.1002/(SICI)1097-4547(19980415)52:2<230::AID-JNR11>3.0.CO;2-B
127. Sharkey J, Ritchie IM, Kelly PA. Perivascular microapplication of endothelin-1: a new model of focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab (1993) 13:865-71. doi:10.1038/jcbfm.1993.108
128. Hunter AJ, Green AR, Cross AJ. Animal models of acute ischaemic stroke: can they predict clinically successful neuroprotective drugs?. Trends Pharmacol Sci (1995) 16:123-8. doi:10.1016/S0165-6147(00)88999-3
129. Leviton A, Gilles FH. An epidemiologic study of perinatal telencephalic leucoencephalopathy in an autopsy population. J Neurol Sci (1973) 18:53-66. doi:10.1016/0022-510X(73)90020-8
130. Leviton A, Gilles FH. Are hypertrophic astrocytes a sufficient criterion of perinatal telencephalic leucoencephalopathy?. J Neurol Neurosurg Psychiatry (1973) 36:383-8. doi:10.1136/jnnp.36.3.383
131. Gilles FH, Leviton A, Kerr CS. Endotoxin leucoencephalopathy in the telencephalon of the newborn kitten. J Neurol Sci (1976) 27:183-91. doi:10.1016/0022-510X(76)90060-5
132. Leviton A, Gilles FH. Acquired perinatal leukoencephalopathy. Ann Neurol (1984) 16:1-8. doi:10.1002/ana.410160102
133. Deng Y, Xie D, Fang M, Zhu G, Chen C, Zeng H, et al. Astrocyte-derived proinflammatory cytokines induce hypomyelination in the periventricular white matter in the hypoxic neonatal brain. PLoS One (2014) 9:e87420. doi:10.1371/journal.pone.0087420
134. Mifsud G, Zammit C, Muscat R, Di Giovanni G, Valentino M. Oligodendrocyte pathophysiology and treatment strategies in cerebral ischemia. CNS Neurosci Ther (2014) 20:603-12. doi:10.1111/cns.12263
135. Stys PK, Ransom BR, Waxman SG, Davis PK. Role of extracellular calcium in anoxic injury of mammalian central white matter. Proc Natl Acad Sci U S A (1990) 87:4212-6. doi:10.1073/pnas.87.11.4212
136. Stys PK, Waxman SG, Ransom BR. Ionic mechanisms of anoxic injury in mammalian CNS white matter: role of Na+ channels and Na(+)-Ca2+ exchanger. J Neurosci (1992) 12:430-9.
137. Baltan S. Ischemic injury to white matter: an age-dependent process. Neuroscientist (2009) 15:126-33. doi:10.1177/1073858408324788
138. Ouardouz M, Nikolaeva MA, Coderre E, Zamponi GW, McRory JE, Trapp BD, et al. Depolarization-induced Ca2+ release in ischemic spinal cord white matter involves L-type Ca2+ channel activation of ryanodine receptors. Neuron (2003) 40:53-63. doi:10.1016/j.neuron.2003.08.016
139. Agrawal SK, Fehlings MG. Role of NMDA and non-NMDA ionotropic glutamate receptors in traumatic spinal cord axonal injury. J Neurosci (1997) 17:1055-63.
140. Matute C, Alberdi E, Domercq M, Sanchez-Gomez MV, Perez-Samartin A, Rodriguez-Antiguedad A, et al. Excitotoxic damage to white matter. J Anat (2007) 210:693-702. doi:10.1111/j.1469-7580.2007.00733.x
141. Kadhim H, Tabarki B, Verellen G, De Prez C, Rona AM, Sebire G. Inflammatory cytokines in the pathogenesis of periventricular leukomalacia. Neurology (2001) 56:1278-84. doi:10.1212/WNL.56.10.1278
142. Kadhim H, Tabarki B, De Prez C, Rona AM, Sebire G. Interleukin-2 in the pathogenesis of perinatal white matter damage. Neurology (2002) 58:1125-8. doi:10.1212/WNL.58.7.1125
143. Folkerth RD, Keefe RJ, Haynes RL, Trachtenberg FL, Volpe JJ, Kinney HC. Interferon-gamma expression in periventricular leukomalacia in the human brain. Brain Pathol (2004) 14:265-74. doi:10.1111/j.1750-3639.2004.tb00063.x
144. Dammann O, Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res (1997) 42:1-8. doi:10.1203/00006450-199707000-00001
145. Smith SE, Li J, Garbett K, Mirnics K, Patterson PH. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci (2007) 27:10695-702. doi:10.1523/JNEUROSCI.2178-07.2007
146. Deguchi K, Oguchi K, Takashima S. Characteristic neuropathology of leukomalacia in extremely low birth weight infants. Pediatr Neurol (1997) 16:296-300. doi:10.1016/S0887-8994(97)00041-6
147. Meng SZ, Arai Y, Deguchi K, Takashima S. Early detection of axonal and neuronal lesions in prenatal-onset periventricular leukomalacia. Brain Dev (1997) 19:480-4. doi:10.1016/S0387-7604(97)00068-5
148. Bakiri Y, Hamilton NB, Karadottir R, Attwell D. Testing NMDA receptor block as a therapeutic strategy for reducing ischaemic damage to CNS white matter. Glia (2008) 56:233-40. doi:10.1002/glia.20608
149. Bakiri Y, Burzomato V, Frugier G, Hamilton NB, Karadottir R, Attwell D. Glutamatergic signaling in the brain's white matter. Neuroscience (2009) 158:266-74. doi:10.1016/j.neuroscience.2008.01.015
150. Dewar D, Underhill SM, Goldberg MP. Oligodendrocytes and ischemic brain injury. J Cereb Blood Flow Metab (2003) 23:263-74. doi:10.1097/00004647-200303000-00001
151. Yoshizaki K, Adachi K, Kataoka S, Watanabe A, Tabira T, Takahashi K, et al. Chronic cerebral hypoperfusion induced by right unilateral common carotid artery occlusion causes delayed white matter lesions and cognitive impairment in adult mice. Exp Neurol (2008) 210:585-91. doi:10.1016/j.expneurol.2007.12.005
152. Sotak CH. The role of diffusion tensor imaging in the evaluation of ischemic brain injury-a review. NMR Biomed (2002) 15:561-9. doi:10.1002/nbm.786
153. Deng W. Neurobiology of injury to the developing brain. Nat Rev Neurol (2010) 6:328-36. doi:10.1038/nrneurol.2010.53
154. Morken TS, Wideroe M, Vogt C, Lydersen S, Havnes M, Skranes J, et al. Longitudinal diffusion tensor and manganese-enhanced MRI detect delayed cerebral gray and white matter injury after hypoxia-ischemia and hyperoxia. Pediatr Res (2013) 73:171-9. doi:10.1038/pr.2012.170
155. Fuchtemeier M, Brinckmann MP, Foddis M, Kunz A, Po C, Curato C, et al. Vascular change and opposing effects of the angiotensin type 2 receptor in a mouse model of vascular cognitive impairment. J Cereb Blood Flow Metab (2015) 35:476-84. doi:10.1038/jcbfm.2014.221
156. Van de Looij Y, Chatagner A, Quairiaux C, Gruetter R, Huppi PS, Sizonenko SV. Multi-modal assessment of long-term erythropoietin treatment after neonatal hypoxic-ischemic injury in rat brain. PLoS One (2014) 9:e95643. doi:10.1371/journal.pone.0095643
157. Calabrese E, Du F, Garman RH, Johnson GA, Riccio C, Tong LC, et al. Diffusion tensor imaging reveals white matter injury in a rat model of repetitive blast-induced traumatic brain injury. J Neurotrauma (2014) 31:938-50. doi:10.1089/neu.2013.3144
158. Donovan V, Kim C, Anugerah AK, Coats JS, Oyoyo U, Pardo AC, et al. Repeated mild traumatic brain injury results in long-term white-matter disruption. J Cereb Blood Flow Metab (2014) 34:715-23. doi:10.1038/jcbfm.2014.6
159. Khan MB, Hoda MN, Vaibhav K, Giri S, Wang P, Waller JL, et al. Remote ischemic postconditioning: harnessing endogenous protection in a murine model of vascular cognitive impairment. Transl Stroke Res (2015) 6:69-77. doi:10.1007/s12975-014-0374-6
160. Biran V, Joly L-M, Héron A, Vernet A, Véga C, Mariani J, et al. Glial activation in white matter following ischemia in the neonatal P7 rat brain. Exp Neurol (2006) 199:103-12. doi:10.1016/j.expneurol.2006.01.037
161. Cui X, Chopp M, Zacharek A, Ning R, Ding X, Roberts C, et al. Endothelial nitric oxide synthase regulates white matter changes via the BDNF/TrkB pathway after stroke in mice. PLoS One (2013) 8:e80358. doi:10.1371/journal.pone.0080358
162. Xiong M, Li J, Ma S-M, Yang Y, Zhou W-H. Effects of hypothermia on oligodendrocyte precursor cell proliferation, differentiation and maturation following hypoxia ischemia in vivo and in vitro. Exp Neurol (2013) 247:720-9. doi:10.1016/j.expneurol.2013.03.015
163. Deng Y-P, Sun Y, Hu L, Li Z-H, Xu Q-M, Pei Y-L, et al. Chondroitin sulfate proteoglycans impede myelination by oligodendrocytes after perinatal white matter injury. Exp Neurol (2015) 269:213-23. doi:10.1016/j.expneurol.2015.03.026
164. Wenzelburger R, Kopper F, Frenzel A, Stolze H, Klebe S, Brossmann A, et al. Hand coordination following capsular stroke. Brain (2005) 128:64-74. doi:10.1093/brain/awh317
165. Schulz R, Park C-H, Boudrias M-H, Gerloff C, Hummel FC, Ward NS. Assessing the integrity of corticospinal pathways from primary and secondary cortical motor areas after stroke. Stroke (2012) 43:2248-51. doi:10.1161/strokeaha.112.662619
166. Petoe MA, Byblow WD, De Vries EJM, Krishnamurthy V, Zhong CS, Barber PA, et al. A template-based procedure for determining white matter integrity in the internal capsule early after stroke. Neuroimage Clin (2014) 4:695-700. doi:10.1016/j.nicl.2013.12.006
167. Song J, Nair VA, Young BM, Walton LM, Nigogosyan Z, Remsik AB, et al. DTI measures track and predict motor function outcomes in stroke rehabilitation utilizing BCI technology. Front Hum Neurosci (2015) 9:195. doi:10.3389/fnhum.2015.00195